4-HPA was sufficient to reverse obesity and glucose intolerance in HFD-fed mice. Mechanistically, 4-HPA treatment markedly regulates SIRT1 signaling pathways and induces the expression of beige fat and thermogenesis-specific markers in white adipose tissue (WAT). The gene discussed is SIRT1; the disease is Glucose intolerance.